Roldán FMS, Ruano R, Acevedo L

Language: Spanish
References: 9
Page: 36-38
PDF size: 139.55 Kb.

ABSTRACT

Actinomycetoma is a chronic, granulomatous infection, characterized by swelling and fistulas draining sero-purulent material. It is caused by bacteria of the genus Nocardia (86%) and Actinomadura (14%). The lower extremities and trunk are the most affected areas. The immunological pathophysiology and its relationship with immune diseases is still under study. It is necessary to isolate the causal microorganism and the presence of grains on the direct exam for diagnosis. Prolonged treatment with trimethoprim-sulfamethoxazole continues to be one of the first-line drugs. Amikacin is considered useful in complicated or unresponsive cases.

REFERENCES

1. Van de Sande W, Fahal A, Ahmed SA y Serrano JA, Closing the mycetoma knowledge gap, Medical Mycology 2018; 56:153-64.

2. Matos C, Reis S y Galdino de Mendonça E, Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review, An Bras Dermatol 2018; 93(1):8-18.

3. Welsh O, Vera-Cabrera L, Welsh E y Salinas MC, Actinomycetoma and advances in its treatment, Clinics in Dermatology 2012; 30:372-81.

4. Bettesworth J et al., Primary actinomycosis of the foot: a case report and literature review, Journal of the American College of Certified Wound Specialists 2009; 1(3):95-100.

5. Gomes IA, De Carvalho FO, De Menezes AF, Almeida FM, Shanmugam S, De Souza Siqueira Quintans J et al., The role of interleukins in vitiligo: a systematic review, Journal of the European Academy of Dermatology and Venereology 2018. Disponible en: http://dx.doi.org/10.1111/ jdv.15016.

6. Gosselink C et al., Nocardiosis causing pedal actinomycetoma: a case report and review of the literature, The Journal of Foot & Ankle Surgery 2008; 47(5):457-62.

7. Karki S y Abad-Venida ML, A case of actinomycetoma treated with trimethoprim + sulfamethoxazole, Int J Dermatol Clin Res 2015; 1(2):20-3.

8. Gómez-Flores A, Welsh O, Said-Fernández S, Lozano-Garza G, Tavárez- Alejandro RE y Vera-Cabrera L, In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis, Antimicrobial Agents and Chemotherapy 2004; 48(3):832-7.

9. Ameen M y Arenas R, Developments in the management of mycetomas, Clin Exp Dermatol 2009; 34(1):1-7.